Awakn Life Sciences (TSE:AWKN) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Awakn Life Sciences Corp. is collaborating with Eurofins Discovery and Graft Polymer to advance its pre-clinical program for developing new therapeutics aimed at treating mental health and addiction disorders, including Alcohol Use Disorder and PTSD. This partnership is a key move in Awakn’s strategy to bring innovative treatments to the market, potentially benefiting millions suffering from these conditions in North America and Europe.
For further insights into TSE:AWKN stock, check out TipRanks’ Stock Analysis page.